drug

deuruxolitinib phosphate

Marketedupdated 2mo ago

by Sun Pharmaceutical Industries Ltd

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Patent cliff

source: FDA Orange Book

first barrier falls

Jul 25, 2029

~3.1 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (6)

Oct 10, 2044method-of-use (U-3976)US 12364699
May 10, 2044compositionUS 12247034
Aug 11, 2042method-of-use (U-3976)US 12285432
May 21, 2041formulationUS 11919907
May 4, 2037method-of-use (U-3976)US 10561659
May 4, 2037method-of-use (U-3976)US 12076323

FDA exclusivities (1)

Jul 25, 2029NCENew Chemical Entity (5y)3.1y

Data sources

ClinicalTrials.gov

last refreshed 1h ago

Found something off?